Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This drug is a **sterile intravenous crystalloid and carbohydrate combination solution** containing dextrose monohydrate, sodium chloride, sodium lactate, potassium chloride, and calcium chloride. It is marketed as Lactated Ringer's and Dextrose or, in potassium-containing presentations, Potassium Chloride in Lactated Ringer's and Dextrose 5% Injection, and is manufactured by ICU Medical. Pharmacologically, it acts by **expanding and maintaining extracellular fluid volume, replacing essential electrolytes, supplying glucose calories, and providing lactate as a bicarbonate precursor with alkalinizing effect**. It is indicated as a source of water, electrolytes, and calories, and for parenteral replacement of extracellular fluid and electrolyte losses in adults and pediatric patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dextrose monohydrate + potassium chloride + sodium lactate + sodium chloride + calcium chloride.